Droxia Coupons & Prices

Droxia (hydroxyurea) is an FDA-approved medication that helps reduce how often painful sickle cell crises happen and lowers the need for blood transfusions in adults with sickle cell anemia who have recurrent moderate to severe painful crises. Because a generic version of hydroxyurea is available, patients often have more than one path to a lower price at the pharmacy — enter your ZIP above to see today's Droxia coupon price, whether you're insured, on Medicare, or paying cash.

What Is Droxia and How Does It Work?

Droxia is a brand name for hydroxyurea (also called hydroxycarbamide), classified as an antimetabolite and ribonucleotide reductase inhibitor. It is FDA-approved to reduce the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia (sickle cell disease) who have recurrent moderate-to-severe painful crises. Droxia's label does not include a pediatric indication — safety and effectiveness in pediatric patients have not been established for Droxia specifically. A related hydroxyurea brand, Siklos, carries a separate FDA approval for pediatric patients 2 years and older; see the comparison below.

Hydroxyurea, the same active ingredient, is also sold under other brand names for other uses. Hydrea is FDA-approved for certain cancers, including chronic myelogenous leukemia, and is also prescribed off-label for other blood disorders such as polycythemia vera. Droxia's own FDA approval, however, is specifically for sickle cell disease.

Manufacturer Support vs. the Rx.com Cash Coupon

Droxia does not currently have a widely advertised manufacturer copay savings card the way some brand-name drugs do. Its manufacturer, Bristol Myers Squibb, does offer patient assistance and financial-support resources for eligible patients through its official access-support program — eligibility, income requirements, and terms vary, so check directly with the manufacturer if you think you might qualify.

Because manufacturer assistance programs are usually restricted by income or insurance status, the Rx.com cash coupon can be a straightforward option regardless of your coverage — including if you're uninsured, on Medicare (which typically can't use manufacturer copay cards), or if a program application is denied or still pending. Since generic hydroxyurea is available, it's also worth comparing the brand-name Droxia price against the generic price before you fill either one; enter your ZIP above to see current pricing.

Droxia vs. Other Sickle Cell Disease Treatments

If you're comparing options for managing sickle cell disease, it helps to know how these are related:

• Hydrea — the same active ingredient, hydroxyurea, sold under a different brand name and FDA-approved for certain cancers rather than sickle cell disease.
• Siklos — also hydroxyurea, but a separate FDA-approved product. Unlike Droxia, Siklos carries an FDA approval for pediatric patients 2 years and older with sickle cell disease.
• Endari — a different medication (L-glutamine) approved to reduce complications of sickle cell disease; it works differently than hydroxyurea and is sometimes used alongside it.

Because generic hydroxyurea is available, many patients and prescribers compare the cost of brand-name Droxia against the generic before deciding which to fill.

Safety Information

Droxia carries a boxed warning for myelosuppression (bone marrow suppression); your provider will check blood counts before starting treatment and regularly during it, and the drug should not be used if bone marrow function is already markedly depressed. Long-term use has been associated with secondary cancers, including leukemia and skin cancer.

Droxia can cause fetal harm and should be avoided during pregnancy; effective contraception is recommended during treatment and for at least 6 months afterward for females and at least 1 year afterward for males. Other risks include vasculitic skin ulcerations (particularly in patients who have also used interferon therapy) and, rarely, lung problems such as pulmonary fibrosis. An increase in red blood cell size (macrocytosis) is an expected, harmless effect of treatment and does not by itself require stopping folate or B12. This is general information, not medical advice — talk with your provider about your specific health history before starting or stopping Droxia.